BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38239088)

  • 21. The spectrum of peripheral T-cell lymphomas.
    O'leary H; Savage KJ
    Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas.
    Manso R; Rodríguez-Pinilla SM; González-Rincón J; Gómez S; Monsalvo S; Llamas P; Rojo F; Pérez-Callejo D; Cereceda L; Limeres MA; Maeso C; Ferrando L; Pérez-Seoane C; Rodríguez G; Arrinda JM; García-Bragado F; Franco R; Rodriguez-Peralto JL; González-Carreró J; Martín-Dávila F; Piris MA; Sánchez-Beato M
    Haematologica; 2015 Jan; 100(1):e25-7. PubMed ID: 25304611
    [No Abstract]   [Full Text] [Related]  

  • 23. Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.
    Manso R; Sánchez-Beato M; González-Rincón J; Gómez S; Rojo F; Mollejo M; García-Cosio M; Menárguez J; Piris MA; Rodríguez-Pinilla SM
    Br J Haematol; 2018 Nov; 183(3):497-501. PubMed ID: 29076126
    [No Abstract]   [Full Text] [Related]  

  • 24. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.
    Dobay MP; Lemonnier F; Missiaglia E; Bastard C; Vallois D; Jais JP; Scourzic L; Dupuy A; Fataccioli V; Pujals A; Parrens M; Le Bras F; Rousset T; Picquenot JM; Martin N; Haioun C; Delarue R; Bernard OA; Delorenzi M; de Leval L; Gaulard P
    Haematologica; 2017 Apr; 102(4):e148-e151. PubMed ID: 28082343
    [No Abstract]   [Full Text] [Related]  

  • 25. [Recent advance in peripheral T-cell lymphoma, not otherwise specified].
    Duan R; Zhang JZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):427-9. PubMed ID: 21055168
    [No Abstract]   [Full Text] [Related]  

  • 26. Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment.
    Tari G; Lemonnier F; Morschhauser F
    Curr Opin Oncol; 2021 Sep; 33(5):400-405. PubMed ID: 34230442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
    de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
    Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From empiric to mechanism-based therapy for peripheral T cell lymphoma.
    Intlekofer AM; Younes A
    Int J Hematol; 2014 Mar; 99(3):249-62. PubMed ID: 24510453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection and significance of BRAF gene in mature T/NK cell lymphoma].
    Ma C; Zhang X; Zhao Y; Wang G; Zhang M
    Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):816-22. PubMed ID: 26887510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders.
    Miyoshi H; Sato K; Niino D; Arakawa F; Kimura Y; Kiyasu J; Takeuchi M; Yoshida M; Okada Y; Nakamura Y; Sugita Y; Ohshima K
    Am J Clin Pathol; 2012 Jun; 137(6):879-89. PubMed ID: 22586046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigational drugs for T-cell lymphoma.
    Ghez D; Danu A; Ribrag V
    Expert Opin Investig Drugs; 2016; 25(2):171-81. PubMed ID: 26576861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline TET2 loss of function causes childhood immunodeficiency and lymphoma.
    Stremenova Spegarova J; Lawless D; Mohamad SMB; Engelhardt KR; Doody G; Shrimpton J; Rensing-Ehl A; Ehl S; Rieux-Laucat F; Cargo C; Griffin H; Mikulasova A; Acres M; Morgan NV; Poulter JA; Sheridan EG; Chetcuti P; O'Riordan S; Anwar R; Carter CR; Przyborski S; Windebank K; Cant AJ; Lako M; Bacon CM; Savic S; Hambleton S
    Blood; 2020 Aug; 136(9):1055-1066. PubMed ID: 32518946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.
    Debackere K; Marcelis L; Demeyer S; Vanden Bempt M; Mentens N; Gielen O; Jacobs K; Broux M; Verhoef G; Michaux L; Graux C; Wlodarska I; Gaulard P; de Leval L; Tousseyn T; Cools J; Dierickx D
    Nat Commun; 2021 Jun; 12(1):3705. PubMed ID: 34140493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression.
    Huang HS; Liao CK; Liu TT; You HL; Wang MC; Huang WT
    Hum Pathol; 2018 Oct; 80():145-151. PubMed ID: 29885407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Pathogenesis of Peripheral T Cell Lymphoma.
    Sakata-Yanagimoto M; Chiba S
    Curr Hematol Malig Rep; 2015 Dec; 10(4):429-37. PubMed ID: 26431836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral T-cell lymphoma cell line T8ML-1 highlights conspicuous targeting of PVRL2 by t(14;19)(q11.2;q13.3).
    Ehrentraut S; Nagel S; Pommerenke C; Dirks WG; Quentmeier H; Kaufmann M; Meyer C; Zaborski M; Geffers R; Fujiwara H; Drexler HG; MacLeod RAF
    Haematologica; 2017 Sep; 102(9):e356-e359. PubMed ID: 28659334
    [No Abstract]   [Full Text] [Related]  

  • 37. Challenges and implications of genomics for T-cell lymphomas.
    Jacobsen ED; Weinstock DM
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):63-68. PubMed ID: 30504292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination.
    Ma H; O'Connor OA; Marchi E
    Expert Rev Hematol; 2019 Mar; 12(3):137-146. PubMed ID: 30782038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.
    Laginestra MA; Cascione L; Motta G; Fuligni F; Agostinelli C; Rossi M; Sapienza MR; Righi S; Broccoli A; Indio V; Melle F; Tabanelli V; Calleri A; Novero D; Facchetti F; Inghirami G; Sabattini E; Bertoni F; Pileri SA
    Mod Pathol; 2020 Feb; 33(2):179-187. PubMed ID: 31028364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rare case of Lennert's type peripheral T-cell lymphoma with t(14;19)(q11.2;q13.3).
    Shin SY; Jang S; Park CJ; Chi HS; Lee KH; Huh J; Seo EJ
    Int J Lab Hematol; 2012 Jun; 34(3):328-32. PubMed ID: 22122800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.